American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders: DSM-III-R (3rd ed.). Washington, DC: American Psychiatric Association.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.

Biederman, J., Faraone, S. V., Weber, W., Russell, R. L., Rater, M., & Park, K. (1997). Correspondence between DSM-III-R and DSM-IV attention deficit hyperactivity disorder (ADHD). Journal of the American Academy of Child and Adolescent Psychiatry, 36(12), 1682–1687.

Biederman, J., Monuteaux, M. C., Mick, E., Spencer, T., Wilens, T. E., Silva, J. M., et al. (2006). Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. (Research Support, N.I.H., Extramural Research Support, Non-US Gov’t). Psychological Medicine, 36(2), 167–179. doi:10.1017/S0033291705006410.

Blumberg, S. J., Bramlett, M. D., Kogan, M. D., Schieve, L. A., Jones, J. R., & Lu, M. C. (2013). Changes in prevalence of parent-reported autism spectrum disorder in school-aged US Children: 2007 to 2011–2012. National Health Statistics Report, 65.

Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., et al. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33(4), 427–433.

de Bruin, E. I., Ferdinand, R. F., Meester, S., de Nijs, P. F., & Verheij, F. (2007). High rates of psychiatric co-morbidity in PDD-NOS. Journal of Autism and Developmental Disorders, 37(5), 877–886. doi:10.1007/s10803-006-0215-x.

Endicott, J., Spitzer, R. L., Fleiss, J. L., & Cohen, J. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33(6), 766–771.

Frazier, J. A., Biederman, J., Bellordre, C. A., Garfield, S. B., Geller, B., Coffey, B. J., et al. (2001). Should the diagnosis of attention-deficit/hyperactivity disorder be considered in children with pervasive development disorder? Journal of Attention Disorders, 4(4), 203–211.

Gadow, K. D., DeVincent, C. J., Pomeroy, J., & Azizian, A. (2004). Psychiatric symptoms in preschool children with PDD and clinic and comparison samples. Journal of Autism and Developmental Disorders, 34(4), 379–393.

Ghaziuddin, M., Weidmer-Mikhail, E., & Ghaziuddin, N. (1998). Comorbidity of Asperger syndrome: A preliminary report. Journal of Intellectual Disability Research, 42(Pt 4), 279–283.

Ghaziuddin, M., & Zafar, S. (2008). Psychiatric comorbidity of adults with autism spectrum disorders. Clinical Neuropsychiatry, 5(1), 9–12.

Gjevik, E., Eldevik, S., Fjaeran-Granum, T., & Sponheim, E. (2011). Kiddie-SADS reveals high rates of DSM-IV disorders in children and adolescents with autism spectrum disorders. Journal of Autism and Developmental Disorders, 41(6), 761–769. doi:10.1007/s10803-010-1095-7.

Goldstein, S., & Schwebach, A. J. (2004). The comorbidity of pervasive developmental disorder and attention deficit hyperactivity disorder: Results of a retrospective chart review. Journal of Autism and Developmental Disorders, 34(3), 329–339.

Green, J., Gilchrist, A., Burton, D., & Cox, A. (2000). Social and psychiatric functioning in adolescents with Asperger syndrome compared with conduct disorder. Journal of Autism and Developmental Disorders, 30(4), 279–293.

Guttman-Steinmetz, S., Gadow, K. D., & Devincent, C. J. (2009). Oppositional defiant and conduct disorder behaviors in boys with autism spectrum disorder with and without attention-deficit hyperactivity disorder versus several comparison samples. Journal of Autism and Developmental Disorders, 39(7), 976–985. doi:10.1007/s10803-009-0706-7.

Hollingshead, A. B. (1975). Four factor index of social status. New Haven, CT: Yale Press.

Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65–70.

Joshi, G., Biederman, J., Petty, C., Goldin, R. L., Furtak, S. L., & Wozniak, J. (2013). Examining the comorbidity of bipolar disorder and autism spectrum disorders: A large controlled analysis of phenotypic and familial correlates in a referred population of youth with bipolar I disorder with and without autism spectrum disorders. Journal of Clinical Psychiatry, 74(6), 578–586. doi:10.4088/JCP.12m07392.

Joshi, G., Petty, C. R., Fried, R., Wozniak, J., Micco, J. A., Henin, A., et al. (2011). Discriminant and concurrent validity of a simplified DSM-based structured diagnostic instrument for the assessment of autism spectrum disorders in youth and young adults. BMC Psychiatry, 11(1), 204. doi:10.1186/1471-244X-11-204.

Joshi, G., Petty, C., Wozniak, J., Henin, A., Fried, R., Galdo, M., et al. (2010). The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: A large comparative study of a psychiatrically referred population. Journal of Autism and Developmental Disorders, 40(11), 1361–1370. doi:10.1007/s10803-010-0996-9.

Kurita, H., Osada, H., Shimizu, K., & Tachimori, H. (2004). Bipolar disorders in mentally retarded persons with pervasive developmental disorders. Journal of Developmental and Physical Disabilities, 16(4), 377–389.

Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders, 36(8), 1101–1114. doi:10.1007/s10803-006-0147-5.

Lecavalier, L., Gadow, K. D., Devincent, C. J., Houts, C. R., & Edwards, M. C. (2011). Validity of DSM-IV syndromes in preschoolers with autism spectrum disorders. Autism, 15(5), 527–543. doi:10.1177/1362361310391115.

Lee, D. O., & Ousley, O. Y. (2006). Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 16(6), 737–746. doi:10.1089/cap.2006.16.737.

Levy, S. E., Giarelli, E., Lee, L. C., Schieve, L. A., Kirby, R. S., Cunniff, C., et al. (2010). Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States. Journal of Developmental and Behavioral Pediatrics, 31(4), 267–275. doi:10.1097/DBP.0b013e3181d5d03b.

Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., et al. (2006). Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders, 36(7), 849–861. doi:10.1007/s10803-006-0123-0.

Mazefsky, C. A., Oswald, D. P., Day, T. N., Eack, S. M., Minshew, N. J., & Lainhart, J. E. (2012). ASD, a psychiatric disorder, or both? Psychiatric diagnoses in adolescents with high-functioning ASD. Journal of Clinical Child and Adolescent Psychology, 41(4), 516–523. doi:10.1080/15374416.2012.686102.

Muris, P., Steerneman, P., Merckelbach, H., Holdrinet, I., & Meesters, C. (1998). Comorbid anxiety symptoms in children with pervasive developmental disorders. Journal of Anxiety Disorders, 12(4), 387–393.

Oliver, P., Cooray, S., Tyrer, P., & Cicchetti, D. (2003). Use of the global assessment of function scale in learning disability. The British Journal of Psychiatry, 44, S32–S35.

Orvaschel, H., & Puig-Antich, J. (1987). Schedule for Affective Disorders and Schizophrenia for School-Age Children: Epidemiologic Version. Fort Lauderdale, FL: Nova University.

Orvaschel, H. (1994). Schedule for affective disorders and schizophrenia for school-age children epidemiologic version (5th ed.). Ft. Lauderdale: Nova Southeastern University, Center for Psychological Studies.

RUPP. (2002). Research units on pediatric psychopharmacology autism network: Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314–321.

RUPP. (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archives of General Psychiatry, 62(11), 1266–1274. doi:10.1001/archpsyc.62.11.1266.

Russell, E., & Sofronoff, K. (2005). Anxiety and social worries in children with asperger syndrome. Australian and New Zealand Journal of Psychiatry, 39(7), 633–638.

Ryden, E., & Bejerot, S. (2008). Autism spectrum disorders in an adult psychiatric population. A naturalistic cross-sectional controlled study. Clinical Neuropsychiatry, 5(1), 13–21.

Sikora, D. M., Vora, P., Coury, D. L., & Rosenberg, D. (2012). Attention-deficit/hyperactivity disorder symptoms, adaptive functioning, and quality of life in children with autism spectrum disorder. Pediatrics, 130(Suppl 2), S91–S97. doi:10.1542/peds.2012-0900G.

Skokauskas, G., & Gallagher, L. (2012). Mental health aspects of autistic spectrum disorders in children. Journal of Intellectual Disability Research, 56(3), 248–257. doi:10.1111/j.1365-2788.2011.01423.x.

Sterling, L., Dawson, G., Estes, A., & Greenson, J. (2008). Characteristics associated with presence of depressive symptoms in adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 38(6), 1011–1018.

Sukhodolsky, D. G., Scahill, L., Gadow, K. D., Arnold, L. E., Aman, M. G., McDougle, C. J., et al. (2008). Parent-rated anxiety symptoms in children with pervasive developmental disorders: Frequency and association with core autism symptoms and cognitive functioning. Journal of Abnormal Child Psychology, 36(1), 117–128. doi:10.1007/s10802-007-9165-9.

Sverd, J., Dubey, D. R., Schweitzer, R., & Ninan, R. (2003). Pervasive developmental disorders among children and adolescents attending psychiatric day treatment. Psychiatric Services, 54(11), 1519–1525.

Sverd, J., Sheth, R., Fuss, J., & Levine, J. (1995). Prevalence of pervasive developmental disorder in a sample of psychiatrically hospitalized children and adolescents. Child Psychiatry and Human Development, 25(4), 221–240.

Szatmari, P., Bartolucci, G., & Bremner, R. (1989). Asperger’s syndrome and autism: Comparison of early history and outcome. Developmental Medicine and Child Neurology, 31(6), 709–720.

Van Steensel, F. J., Bogels, S. M., & de Bruin, E. I. (2013). Psychiatric comorbidity in children with autism spectrum disorders: A comparison with children with ADHD. Journal of Child and Family Studies, 22(3), 368–376.

Vickerstaff, S., Heriot, S., Wong, M., Lopes, A., & Dossetor, D. (2007). Intellectual ability, self-perceived social competence, and depressive symptomatology in children with high-functioning autistic spectrum disorders. Journal of Autism and Developmental Disorders, 37(9), 1647–1664.

Wechsler, D. (1991). Manual for the Wechsler Intelligence Scale for Children - (3rd ed.). San Antonio: The Psychological Corporation, Harcourt Brace Jovanovich Inc.

Wechsler, D. (1999). Wechsler Abbreviated Scale of Intelligence (WASI) (4th ed.). San Antonio, Tx: The Psychological Corporation.

Weisbrot, D. M., Gadow, K. D., DeVincent, C. J., & Pomeroy, J. (2005). The presentation of anxiety in children with pervasive developmental disorders. Journal of child and adolescent psychopharmacology, 15(3), 477–496. doi:10.1089/cap.2005.15.477.

Weissman, A., & Bates, M. E. (2010). Increased clinical and neurocognitive impairment in children with autism spectrum disorders and comorbid bipolar disorder. Research in Autism Spectrum Disorders, 4(4), 670–680.

White, S. W., Kreiser, N. L., Pugliese, C., & Scarpa, A. (2012). Social anxiety mediates the effect of autism spectrum disorder characteristics on hostility in young adults. Autism, 16(5), 453–464. doi:10.1177/1362361311431951.

Wing, L. (1981). Asperger’s syndrome: A clinical account. Psychological Medicine, 11(1), 115–129.

Wozniak, J., Biederman, J., Faraone, S. V., Frazier, J., Kim, J., Millstein, R., et al. (1997). Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry, 36(11), 1552–1559; discussion 1559–1560. doi:10.1016/S0890-8567(09)66564-3.

Wozniak, J., Biederman, J., Mick, E., Waxmonsky, J., Hantsoo, L., Best, C., et al. (2007). Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial. European Neuropsychopharmacology, 17(6–7), 440–447. doi:10.1016/j.euroneuro.2006.11.006.